tirzepatide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42269776
GLP-1 receptor agonist adjunct therapy stabilises Ramadan dysglycaemia in insulin-treated diabetes: a CGM-based study.
GLP-1 receptor agonist adjunct therapy stabilises Ramadan dysglycaemia in insulin-treated diabetes: a CGM-based study.
- 저자
- Tanveer Ashraf, Nader Lessan
- 저널
- Diabetes research and clinical practice
- 공개일
- 2026 Aug
- 연구 유형
- 기타
- DOI
- 10.1016/j.diabres.2026.113369
문헌 요약
Patients with type 1 and insulin-treated type 2 diabetes are at higher risk of hypo- and hyperglycaemia during Ramadan fasting. The role of incretin-based add-on therapy (GLP-1 receptor agonist semaglutide and the GLP-1/GIP dual agonist tirzepatide) in attenuating Ramadan dysglycaemia in insulin-treated type 2 diabetes has not been characterised using con…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.